InMed Prognostics - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2018, InMed Prognostics operates in Health Tech industry. Initially focusing on neurodegenerative diseases, the company has leveraged imaging and AI to offer comprehensive diagnostic insigh...
Funding stage:
Seed
Last funding:
11/12/2022
Total funding:
$2.20 Mn+
Investors
Employee count:
15
Last 90d
15
Last 90d
Glassdoor Rating:
InMed Prognostics: Funding Highlights
Funding highlights of InMed Prognostics and a snapshot of its key metrics.
Total Funding$2.20 Mn+
Current StageEarly Stage
Total Round(s)4
Funding Rounds
FAQs on Funding of InMed Prognostics
Health Tech Funded InMed Prognostics has raised a total funding of $2.20 million as of 12 December 2022 across 4 rounds. Find the details around funding rounds, participating investors, and other insights of InMed Prognostics here...
InMed Prognostics has raised a total of $2.20 million across 4 funding rounds and the last round was raised on 12 December 2022.
InMed Prognostics's key investors include Biotechnology Industry Research Assistance Council(BIRAC), Exxora, India EdisonTM Accelerator and 1 other.
InMed Prognostics's latest funding round was $2.13 million in Early Stage, raised on 12 December 2022.
InMed Prognostics is at the Early stage. Its most recent round was raised on 12 December 2022.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links